XML 92 R80.htm IDEA: XBRL DOCUMENT v3.25.3
SEGMENT INFORMATION - Schedule of Reportable Segments (Details)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2025
USD ($)
segment
Sep. 30, 2024
USD ($)
Segment Reporting [Abstract]        
Number of reportable segments | segment     3  
Financial information regarding the Company's reportable segments        
Net Sales $ 961,131 $ 909,291 $ 2,814,445 $ 2,734,802
Cost of Sales (exclusive of depreciation and amortization): 598,046 558,511 1,747,931 1,708,707
Selling, Research & Development and Administrative: 148,760 141,604 455,176 443,714
Acquisition related costs (1,896) 0 (2,240) (140)
Restructuring Initiatives (2,168) (3,864) (5,789) (9,659)
Curtailment gain related to restructuring initiatives 0 1,851 0 1,851
Net unrealized investment gain (loss) (161) 1,043 845 1,495
Gain from remeasurement of equity method investment 26,518 0 26,518 0
Other special items (4,400) 0 (4,400) 0
Depreciation and amortization (75,234) (67,015) (210,785) (196,332)
Interest Expense (13,532) (12,290) (35,733) (32,526)
Interest Income 2,400 3,022 7,094 9,022
Income before Income Taxes 154,127 131,131 399,856 353,695
Optimization initiative        
Financial information regarding the Company's reportable segments        
Restructuring Initiatives (2,168) (3,864) (5,789) (9,676)
Prior year initiatives        
Financial information regarding the Company's reportable segments        
Restructuring Initiatives 0 0 0 17
Aptar Pharma        
Financial information regarding the Company's reportable segments        
Net Sales 445,410 420,594 1,297,466 1,242,420
Aptar Beauty        
Financial information regarding the Company's reportable segments        
Net Sales 327,768 302,859 968,324 951,666
Aptar Closures        
Financial information regarding the Company's reportable segments        
Net Sales 187,953 185,838 548,655 540,716
Operating Segment        
Financial information regarding the Company's reportable segments        
Net Sales 970,317 917,032 2,841,582 2,762,563
Adjusted EBITDA 235,855 223,795 678,490 637,512
Depreciation and amortization (74,360) (66,119) (208,236) (194,069)
Operating Segment | Aptar Pharma        
Financial information regarding the Company's reportable segments        
Net Sales 445,656 420,753 1,298,170 1,243,026
Cost of Sales (exclusive of depreciation and amortization): 221,402 209,981 651,418 637,523
Selling, Research & Development and Administrative: 63,539 58,779 186,725 179,883
Other Segment Items: (5,300) 240 (5,727) (246)
Adjusted EBITDA 165,769 151,594 465,050 425,260
Restructuring Initiatives (919) (564) (1,177) (653)
Depreciation and amortization (35,107) (30,787) (100,424) (89,198)
Operating Segment | Aptar Beauty        
Financial information regarding the Company's reportable segments        
Net Sales 334,929 308,955 989,481 972,535
Cost of Sales (exclusive of depreciation and amortization): 243,004 217,824 708,430 685,349
Selling, Research & Development and Administrative: 47,746 45,115 142,896 142,021
Other Segment Items: (2,731) (301) (6,962) (1,697)
Adjusted EBITDA 39,749 40,221 123,960 125,993
Restructuring Initiatives (550) (1,962) (1,571) (5,871)
Depreciation and amortization (24,332) (20,420) (65,869) (62,174)
Operating Segment | Aptar Closures        
Financial information regarding the Company's reportable segments        
Net Sales 189,732 187,324 553,931 547,002
Cost of Sales (exclusive of depreciation and amortization): 135,246 131,737 390,999 388,160
Selling, Research & Development and Administrative: 22,895 22,407 69,765 67,469
Other Segment Items: (525) (286) (1,589) (1,172)
Adjusted EBITDA 30,337 31,980 89,480 86,259
Restructuring Initiatives (702) (877) (2,944) (2,530)
Depreciation and amortization (14,921) (14,912) (41,943) (42,697)
Intersegment        
Financial information regarding the Company's reportable segments        
Net Sales (9,186) (7,741) (27,137) (27,761)
Intersegment | Aptar Pharma        
Financial information regarding the Company's reportable segments        
Net Sales (246) (159) (704) (606)
Intersegment | Aptar Beauty        
Financial information regarding the Company's reportable segments        
Net Sales (7,161) (6,096) (21,157) (20,869)
Intersegment | Aptar Closures        
Financial information regarding the Company's reportable segments        
Net Sales (1,779) (1,486) (5,276) (6,286)
Corporate & Other        
Financial information regarding the Company's reportable segments        
Adjusted EBITDA (13,255) (15,411) (54,144) (57,528)
Restructuring Initiatives 3 (461) (97) (605)
Depreciation and amortization $ (874) $ (896) $ (2,549) $ (2,263)